Michael Kastan

Michael Kastan


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2015 in Annual Review of Medicine
Verified
Journal Article
Closed access
MGMichael Goldstein
Michael Goldstein
MKMichael Kastan
Michael Kastan
Cellular responses to DNA damage are important determinants of both cancer development and cancer outcome following radiation therapy and chemotherapy. Identification of molecular pathways governing DNA damage signaling and DNA repair in response to different types of DNA lesions allows for a better understanding of the effects of radiation and chemotherapy on normal and tumor cells. Although dysregulation of the DNA damage response (DDR) is associated with predisposition to cancer development, it can also result in hypersensitivity or resistance of tumors to therapy and can be exploited for improvement of cancer treatment. We highlight the DDR pathways that are activated after treatment with radiation and different classes of chemotherapeutic drugs and describe mechanisms determining tumor sensitivity and resistance to these agents. Further, we discuss approaches to enhance tumor sensitivity to radiation and chemotherapy by modulating the DDR with a goal of enhancing the effectiveness of cancer therapies.

9 February 2012 in Blood
Verified
Journal Article
Open access
PDF file
YVYasmine A. Valentin-Vega
Yasmine A. Valentin-Vega
KMKirsteen H. MacLean
Kirsteen H. MacLean
JTJacqueline Tait-Mulder
Jacqueline Tait-Mulder
SMSandra Milasta
Sandra Milasta
MSMeredith Steeves
Meredith Steeves
MKMichael Kastan
Michael Kastan
Ataxia-telangiectasia mutated (ATM) plays a central role in DNA damage responses, and its loss leads to development of T-cell malignancies. Here, we show that ATM loss also leads to intrinsic mitochondrial abnormalities in thymocytes, including elevated reactive oxygen species, increased aberrant mitochondria, high cellular respiratory capacity, and decreased mitophagy. A fraction of ATM protein is localized in mitochondria, and it is rapidly activated by mitochondrial dysfunction. Unexpectedly, allelic loss of the autophagy regulator Beclin-1 significantly delayed tumor development in ATM-null mice. This effect was not associated with rescue of DNA damage signaling but rather with a significant reversal of the mitochondrial abnormalities. These data support a model in which ATM plays direct roles in modulating mitochondrial homeostasis and suggest that mitochondrial dysfunction and associated increases in mitochondrial reactive oxygen species contribute to the cancer-prone phenotype observed in organisms lacking ATM. Thus, ataxia-telangiectasia should be considered, at least in part, as a mitochondrial disease.

30 September 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MGMichael Goldstein
Michael Goldstein
FDFrederick A. Derheimer
Frederick A. Derheimer
JTJacqueline Tait-Mulder
Jacqueline Tait-Mulder
MKMichael Kastan
Michael Kastan
Significance: Recognition and repair of DNA lesions are critical for maintaining genomic stability and reducing the generation of mutations that lead to cancer development. A mechanism of chromatin alteration is described here that is essential for repair of DNA double-strand breaks. The histone chaperone, nucleolin, is recruited to sites of DNA breaks via binding to RAD50 of the MRE11-NBS1-RAD50 complex, where it removes histone proteins H2A and H2B from the nucleosome at the break site. This nucleosome disruption allows DNA repair proteins to access the DNA lesion and facilitate repair of the DNA break. Clinical implications of these findings include the identification of new targets, such as nucleolin, that could be modulated to enhance sensitivity of tumor cells to radiation therapy.

1 May 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JCJing Chen
Jing Chen
KGKexiao Guo
Kexiao Guo
MKMichael Kastan
Michael Kastan
Ribosomal protein RPL26 enhances p53 translation after DNA damage, and this regulation depends upon interactions between the 5'- and 3'-UTRs of human p53 mRNA (Takagi, M., Absalon, M. J., McLure, K. G., and Kastan, M. B. (2005) Cell 123, 49-63; Chen, J., and Kastan, M. B. (2010) Genes Dev. 24, 2146-2156). In contrast, nucleolin (NCL) suppresses the translation of p53 mRNA and its induction after DNA damage. We confirmed reports that RPL26 and NCL interact with each other and then explored the potential role of this interaction in the translational control of p53 after stress. NCL repression of p53 translation utilizes both the 5'- and 3'-UTRs of p53 mRNA, and NCL binds to the same 5'-3'-UTR interaction region that is critical for the recruitment of RPL26 to p53 mRNA after DNA damage. We also found that NCL is able to oligomerize, consistent with a model in which NCL stabilizes this double-stranded RNA structure. We found that the RNA-binding domain of NCL participates in binding to p53 mRNA, is required for both NCL dimerization and NCL-mediated translational repression, and is the domain of NCL that interacts with RPL26. Excessive RPL26 disrupts NCL dimerization, and point mutations in the NCL-interacting region of RPL26 reduce NCL-RPL26 interactions and attenuate both RPL26 binding to human p53 mRNA and p53 induction by RPL26. These observations suggest a model in which the base pairings in the p53 UTR interaction regions are critical for both translational repression and stress induction of p53 by NCL and RPL26, respectively, and that disruption of a NCL-NCL homodimer by RPL26 may be the switch between translational repression and activation after stress.

1 July 2017 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
JCJing Chen
Jing Chen
JCJohn Crutchley
John Crutchley
DZDadong Zhang
Dadong Zhang
KOKouros Owzar
Kouros Owzar
MKMichael Kastan
Michael Kastan
Cellular responses to DNA damage are critical determinants of cancer development and aging-associated pathogenesis. Here, we identify and characterize a DNA-damage response (DDR) pathway that regulates alternative splicing of numerous gene products, including the human tumor suppressor TP53, and controls DNA damage–induced cellular senescence. In brief, ionizing radiation (IR) inhibits the activity of SMG1, a phosphoinositide-3-kinase-like kinase family member, reducing the binding of SMG1 to a specific region near exon 9 of p53 precursor mRNA and promoting the binding of ribosomal protein L26 (RPL26) to p53 pre-mRNA. RPL26, in turn, is required for the recruitment of the serine/arginine-rich splicing factor SRSF7 to p53 pre-mRNA and generation of alternatively spliced p53β RNA. Disruption of this pathway via selective knockout of p53β by CRISPR/Cas9 or downregulation of pathway constituents significantly reduces IR-induced senescence markers, and cells lacking p53β expression fail to transcriptionally repress negative regulators of cellular senescence and aging.Significance: We identified a new component of the DDR pathway that regulates alternative splicing of messenger RNAs, including human TP53 mRNA. Modulation of this regulatory pathway affects DNA-damage induction of cellular senescence markers. Cancer Discov; 7(7); 766–81. ©2017 AACR.This article is highlighted in the In This Issue feature, p. 653

13 May 2012 in Autophagy
Verified
Journal Article
Open access
PDF file
YVYasmine A. Valentin-Vega
Yasmine A. Valentin-Vega
MKMichael Kastan
Michael Kastan
The various pathologies in ataxia telangiectasia (A-T) patients including T-cell lymphomagenesis have been attributed to defects in the DNA damage response pathway because ATM, the gene mutated in this disease, is a key mediator of this process. Analysis of Atm-deficient thymocytes in mice reveals that the absence of this gene results in altered mitochondrial homeostasis, a phenomenon that appears to result from abnormal mitophagy engagement. Interestingly, allelic loss of the autophagic gene Becn1 delays tumorigenesis in Atm-null mice presumably by reversing the mitochondrial abnormalities and not by improving the DNA damage response (DDR) pathway. Thus, ATM plays a critical role in modulating mitochondrial homeostasis perhaps by regulating mitophagy.